Losartan indications and usage: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Losartan}} {{CMG}}; {{AE}} {{SS}} ==Indications and Usage== ===Hypertension=== COZAAR is indicated for the treatment of hypertension. It may be used alone o...")
 
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Losartan#Adult Indications and Dosage]]
{{Losartan}}
{{CMG}}; {{AE}} {{SS}}
 
==Indications and Usage==
 
===Hypertension===
 
COZAAR is indicated for the treatment of [[hypertension]]. It may be used alone or in combination with other antihypertensive agents, including [[diuretics]].
 
===Hypertensive Patients with Left Ventricular Hypertrophy===
 
COZAAR is indicated to reduce the risk of stroke in patients with [[hypertension]]and left ventricular [[hypertrophy]], but there is evidence that this benefit does not apply to Black patients. (See PRECAUTIONS, Race and CLINICAL PHARMACOLOGY, Pharmacodynamics and Clinical Effects, Reduction in the Risk of Stroke, Race.)
 
===Nephropathy in Type 2 Diabetic Patients===
 
COZAAR is indicated for the treatment of diabetic nephropathy with an elevated serum creatinine and [[proteinuria]] (urinary albumin to creatinine ratio ≥300 mg/g) in patients with type 2 diabetes and a history of [[hypertension]]. In this population, COZAAR reduces the rate of progression of nephropathy as measured by the occurrence of doubling of serum creatinine or end stage renal disease (need for dialysis or renal transplantation) (see CLINICAL PHARMACOLOGY, Pharmacodynamics and Clinical Effects).<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = COZAAR (LOSARTAN POTASSIUM) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ac32c20-169d-475a-fc8a-934f758d6ab0 | publisher =  | date =  | accessdate = 20 February 2014 }}</ref></div>
 
==References==
 
{{Reflist}}
 
{{Angiotensin II receptor antagonists}}
 
[[Category:Alcohols]]
[[Category:Angiotensin II receptor antagonists]]
[[Category:Imidazoles]]
[[Category:Organochlorides]]
[[Category:Tetrazoles]]
[[Category:Biphenyls]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 01:15, 22 July 2014